ESC Premium Access

Intravenous administration of atorvastatin early after cardiac ischemia attenuates adverse left ventricular remodeling, ameliorates cardiac function and limits the deleterious effects of reinfarction

Congress Presentation

About the speaker

Doctor Gemma Vilahur

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)
9 presentations
0 follower

11 more presentations in this session

Mechanistic insight on the cardioprotective effect of levosimendan against doxorubicin induced cardiomyopathy: Pivotal role of PKA signaling.

Speaker: Professor I. Andreadou (Athens, GR)

Thumbnail

Endothelial adenosine-to-inosine RNA editing is indispensable for vascular integrity

Speaker: Doctor S. Tual-Chalot (Newcastle-Upon-Tyne, GB)

Thumbnail

Impact of 719 trp>arg polymorphism of kif 6 gene on contrast induced nephropathy and modulation of statin therapy effectiveness

Speaker: Associate Professor G. De Luca (Novara, IT)

Thumbnail

Carvedilol and its analogue VK-II-86 attenuate stretch-induced manifestations of mechanoelectric feedback.

Speaker: Miss I. Del Canto Serrano (Valencia, ES)

Thumbnail

Uremic toxin induced endothelial dysfunction can be restored by inhibition of the aryl hydrocarbon receptor: implications for cardiovascular disease treatment in chronic kidney disease patients

Speaker: Doctor A. Kompa (Melbourne, AU)

Thumbnail

Access the full session

Poster Session 4 - Pharmacology, angiogenesis and cardiovascular disease

Speakers: Doctor G. Vilahur, Professor I. Andreadou, Doctor S. Tual-Chalot, Associate Professor G. De Luca, Miss I. Del Canto Serrano...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk